tiprankstipranks
Ryman Healthcare Ltd. (RHCGF)
OTHER OTC:RHCGF
Holding RHCGF?
Track your performance easily

Ryman Healthcare (RHCGF) Income Statement

7 Followers

Ryman Healthcare Income Statement

Last quarter (Q4 2022), Ryman Healthcare's total revenue was $1.25B, an increase of Infinity% from the same quarter last year. In Q4, Ryman Healthcare's net income was $―. See Ryman Healthcare’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 23Mar 22Mar 21Mar 20Mar 19
Total Revenue
$ 2.70B$ 1.00B$ 503.76M$ 452.41M$ 422.11M$ 380.95M
Cost of Revenue
------
Gross Profit
--$ 503.76M$ 452.41M$ 422.11M$ 380.95M
Operating Expense
--$ 501.94M$ 427.67M$ 377.87M$ 326.87M
Operating Income
--$ 1.82M$ 24.74M$ 44.25M$ 54.08M
Net Non Operating Interest Income Expense
--$ -30.62M$ -19.26M$ -18.76M$ -18.43M
Other Income Expense
--$ 750.88M$ 405.02M$ 145.66M$ 293.76M
Pretax Income
--$ 722.08M$ 410.50M$ 171.15M$ 329.42M
Tax Provision
--$ 29.21M$ -12.56M$ -93.56M$ 3.43M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
--$ 692.87M$ 423.06M$ 264.71M$ 325.99M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
--$ 692.87M$ 423.06M$ 264.71M$ 325.99M
Normalized Income
--$ 692.87M$ 433.93M$ 264.71M$ 325.99M
Interest Expense
--$ 30.46M$ 18.99M$ 19.07M$ 18.96M
EBIT
--$ 752.54M$ 429.49M$ 190.21M$ 348.37M
EBITDA
-$ 457.98M$ 788.24M$ 461.86M$ 218.83M$ 371.50M
Currency in NZD

Ryman Healthcare Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis